Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

35.97 +0.27 (+0.76%)
Streaming Delayed Price Updated: 4:00 PM EST, Mar 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,134,415
Open 34.56
Bid (Size) 34.00 (100)
Ask (Size) 38.00 (100)
Prev. Close 35.70
Today's Range 34.34 - 36.27
52wk Range 28.66 - 117.33
Shares Outstanding 115,926,629
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Deadline to Lead in Securities Class Action Against Corcept Therapeutics, Inc. (CORT) is April 21, 2026 - Contact Kaplan Fox
NEW YORK, NY - March 2, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (NASDAQ:... 
Via TheNewswire.com
Topics Lawsuit

Performance

YTD
-5.8%
-5.8%
1 Month
-11.6%
-11.6%
3 Month
-54.9%
-54.9%
6 Month
-49.6%
-49.6%
1 Year
-39.1%
-39.1%

More News

Read More
News headline image
Deadline Approaching: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
From Law Offices of Howard G. Smith
Via Business Wire
Corcept Therapeutics (NASDAQ:CORT) Stock Falls After Q4 Earnings Miss Estimates ↗
Via Chartmill
Topics Earnings
News headline image
Important Notice to Long-Term Shareholders of Corcept Therapeutics, Inc. (NASDAQ: CORT); Five9, Inc. (NASDAQ: FIVN); Integer Holdings Corp. (NYSE: ITGR); and Kyndryl Holdings (NYSE: KD): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Lawsuit - Deadline is April 21, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
Kaplan Fox Alerts Corcept Therapeutics, Inc. (CORT) Investors to a Securities Class Action Lawsuit - Deadline is April 21, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
CORT DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit Against Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
CORT DEADLINE FOR LEADERSHIP is April 21, 2026 in a Securities Fraud Lawsuit Against Corcept Therapeutics, Inc. (CORT) - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
Kaplan Fox Reminds Corcept Therapeutics, Inc. (CORT) Investors of a Securities Class Action Deadline on April 21, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
Via TheNewswire.com
Topics Lawsuit
News headline image
Corcept Therapeutics (NASDAQ: CORT) Investors Who Have Suffered Losses - Contact Kaplan Fox before April 21, 2026 Lead Plaintiff Deadline
Via NewMediaWire
Topics Lawsuit
News headline image
CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Corcept Therapeutics Incorporated Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Law Offices of Howard G. Smith Encourages Corcept Therapeutics Incorporated (CORT) Shareholders To Inquire About Securities Fraud Class Action
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
CORT Investors Deadline Alert: Kaplan Fox Announces Corcept Therapeutics, Inc. Securities Class Action Filed - Lead Plaintiff Deadline April 21, 2026
Via NewMediaWire
Topics Lawsuit
News headline image
CORT Investors Deadline Alert: Kaplan Fox Announces Corcept Therapeutics, Inc. Securities Class Action Filed - Lead Plaintiff Deadline April 21, 2026
Via TheNewswire.com
Topics Lawsuit
News headline image
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CORT
From The DJS Law Group
Via Business Wire
News headline image
CORT Stock Slips After-Hours On Weak Q4 Print: Retail Is Watching April FDA Meeting For Relacorilant As Next Catalyst ↗
Via Stocktwits
News headline image
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Corcept (NASDAQ:CORT) Misses Q4 CY2025 Sales Expectations
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2025 Audited Financial Results, Provides Corporate Update
From Corcept Therapeutics Incorporated
Via Business Wire

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?
Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?
Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?
The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market
What is the current price of Corcept Therapeutics Incorporated - Common Stock?
The current price of Corcept Therapeutics Incorporated - Common Stock is 35.97
When was Corcept Therapeutics Incorporated - Common Stock last traded?
The last trade of Corcept Therapeutics Incorporated - Common Stock was at 03/02/26 04:00 PM ET
What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?
The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 4.17B
How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?
Corcept Therapeutics Incorporated - Common Stock has 4B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.